Octavius Pharma has developed DC granules of Dimenhydrinate for making its film-coated tablets. The product has been developed to produce uniform particles that help give better flowability in a way that facilitates tablet compression, maintaining content uniformity. Finished tablets’ specifications and dissolution profile comply as per USP and IH specifications.
| Strength | 50 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | USP, IH |
| API DMF | Available |
| CTD Dosssier | Available |
Dimenhydrinate Tablets are used to prevent and treat nausea, vomiting, dizziness, and vertigo associated with motion sickness. They help reduce symptoms caused by travel by car, sea, air, or other forms of transportation.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields